In December 2022, the UK Health Security Agency reported 19 pediatric deaths from invasive Group A Strep in two months, the highest seasonal toll in over a decade. France, Netherlands, Sweden, Ireland, and Spain reported similar surges. CDC's Emerging Infections Program documented an above-baseline 2022-2024 increase across multiple US states. The bacterium responsible is one that most people have carried in their throats at some point without consequence.
Group A Strep (Streptococcus pyogenes) causes strep throat, scarlet fever, and skin infections in tens of millions of people per year, almost all benign. Invasive Group A Strep (iGAS) is when the same bacterium breaches sterile tissue and causes bloodstream infection, necrotizing fasciitis, pneumonia, or streptococcal toxic shock syndrome. iGAS is the deadly cousin, and it has been rising since 2022. This post sits inside the infection prevention guide and complements the Mycoplasma pneumoniae resurgence post and pertussis whooping cough guide.
Key Takeaways
- Invasive Group A Strep (iGAS) is bloodstream, deep tissue, or sterile-site infection by Streptococcus pyogenes.
- The M1UK lineage drove the 2022-2024 surge in Europe; a similar pattern was seen in the US.
- Pediatric and adult cases both rose, with deaths from necrotizing fasciitis, bacteremia, and toxic shock.
- Risk factors include recent viral infection (especially flu, RSV, varicella), skin breakdown, IV drug use, and chronic illness.
- Early recognition of severe pain disproportionate to skin findings, high fever, and rapid deterioration is critical.
- Penicillin remains first-line; clindamycin is added for severe disease.
What is iGAS?
Invasive Group A Strep refers to Streptococcus pyogenes infection at a normally sterile body site or with systemic features. The bacterium normally lives in the throat and on the skin without causing disease in roughly 5 to 15 percent of school-age children. When it breaches mucosal or skin barriers, the same bacterium can cause severe disease within hours.
The major iGAS syndromes:
- Bacteremia and sepsis: Group A Strep in the bloodstream
- Necrotizing fasciitis: rapidly spreading destruction of fascia and soft tissue
- Streptococcal toxic shock syndrome (STSS): superantigen-driven shock
- Pneumonia and empyema: Group A Strep lower respiratory infection
- Meningitis: uncommon but rapidly progressive
- Puerperal sepsis: postpartum invasive infection
Non-invasive Group A Strep (strep throat, impetigo, scarlet fever) is far more common and usually resolves with oral antibiotics. The non-invasive forms are sometimes called superficial GAS to distinguish them.
Why are cases rising?
Three factors appear to be combining.
Immunity gap from pandemic restrictions: Like Mycoplasma pneumoniae and RSV, Group A Strep had suppressed circulation during 2020-2022 lockdowns and rebounded above baseline as restrictions ended. Children born after 2018 entered the post-pandemic period without typical strep exposure, and clinical disease followed.
M1UK lineage emergence: The M1UK strain, first identified in the UK in 2019, produces more streptococcal pyrogenic exotoxin A (SpeA) than parent M1 strains. It has spread across Europe and the US since 2022 and is associated with increased toxin-mediated disease.
Co-infection with respiratory viruses: The 2022-2024 winters saw simultaneous waves of flu, RSV, and SARS-CoV-2 creating mucosal damage that facilitated bacterial invasion. Children with recent viral infection are at substantially elevated iGAS risk for 1 to 2 weeks following.
| Year | UK pediatric iGAS deaths | Cause |
|---|---|---|
| 2018-2019 | 4 | Baseline |
| 2019-2020 | 3 | Baseline |
| 2020-2022 | 0 to 2 | Pandemic suppression |
| 2022-2023 | 38 | Surge with M1UK |
| 2023-2024 | 19 | Continued elevation |
| 2024-2025 | 12 | Returning toward baseline |
What are the warning signs?
Recognizing severe iGAS early is the hardest part of management because the early picture often looks like ordinary strep throat or a minor skin infection.
Soft tissue and skin:
- Severe pain out of proportion to visible skin findings
- Rapid redness expansion (visible spreading within hours)
- Bullae or hemorrhagic blisters
- Skin discoloration progressing to dusky purple or black
- Crepitus (gas crackling under skin) in necrotizing fasciitis
Systemic:
- Fever above 39 degrees C
- Rapid heart rate and breathing disproportionate to fever
- Hypotension
- Confusion, lethargy
- In children: change in level of activity or feeding
- Rash that does not blanch when pressed (in toxic shock or sepsis)
Any of these in a child with sore throat, skin infection, or recent viral illness warrants urgent medical evaluation. Necrotizing fasciitis can progress from minor injury to amputation within 24 hours.
How is it treated?
iGAS requires aggressive antimicrobial therapy plus, in many cases, surgical source control.
Antibiotic therapy:
- Penicillin G or ampicillin remains the first-line agent
- Clindamycin is added for severe disease (necrotizing fasciitis, STSS) because it suppresses toxin production
- Vancomycin or linezolid for penicillin-allergic patients
- IV immune globulin (IVIG) for streptococcal toxic shock syndrome
Surgical:
- Emergency surgical exploration for any suspected necrotizing soft tissue infection
- Aggressive debridement of devitalized tissue
- Often repeated within 24 hours to remove additional necrotic tissue
Supportive:
- ICU admission for STSS or sepsis
- Aggressive fluid resuscitation
- Vasopressors as needed
- Mechanical ventilation for respiratory failure or ARDS
Survival depends on time to treatment. Necrotizing fasciitis with delayed surgery has 40 to 80 percent mortality. Same condition with surgical intervention within 4 to 6 hours has 20 to 30 percent mortality. The difference is the speed of recognition.
Who is at elevated risk?
iGAS can affect anyone, but certain factors increase risk:
- Recent viral infection (flu, RSV, varicella, COVID-19): 1 to 2 week post-viral window
- Children under 10 and adults over 65
- Skin breakdown (eczema, surgical wounds, injection drug use)
- Postpartum women (puerperal sepsis is historically a major killer)
- Chronic conditions (diabetes, cancer, immunosuppression, alcoholism)
- Crowded settings (households, daycares, military barracks during outbreaks)
Household contacts of an iGAS case face elevated risk for 30 days. Some health authorities recommend antibiotic prophylaxis for household contacts of severe pediatric cases, though guidelines vary by country.
How do you prevent iGAS?
Prevention is layered.
Reduce transmission:
- Wash hands frequently with soap and water (see the hand hygiene technique guide)
- Cover coughs and sneezes
- Stay home with strep throat or skin infection until 24 hours of antibiotics
- Treat strep throat promptly when diagnosed to clear the bacterium
Manage skin:
- Treat eczema and cuts; keep them covered until healed
- Watch wounds for redness, warmth, and spreading lines
- Vaccinate against varicella; chickenpox lesions are a major iGAS gateway
During viral surges:
- Recognize that respiratory viruses raise iGAS risk for 1 to 2 weeks
- Watch for new fever, severe pain, or skin changes during recovery from flu, RSV, or COVID-19
- Seek prompt evaluation for skin redness expanding rapidly
A Group A Strep vaccine has been in development for decades. Two candidates are in Phase 1 and Phase 2 trials in 2026, but no licensed vaccine exists.
FAQ
Can adults get iGAS too?
Yes. Adult iGAS often presents as bacteremia, necrotizing fasciitis (especially in IV drug users), pneumonia, or post-influenza secondary infection. Adult mortality from STSS approaches 50 to 60 percent. Cases in older adults are often missed because the presentation is less specific than in children.
Is iGAS the same as flesh-eating bacteria?
iGAS can cause necrotizing fasciitis, which is one of the "flesh-eating" infections in popular usage. The same clinical syndrome is caused by Vibrio vulnificus, Clostridium species, and polymicrobial infections. Group A Strep is one of the more common causes. See the Vibrio vulnificus post for comparison.
Should I take antibiotics if I'm exposed to someone with iGAS?
Routine prophylaxis is not recommended for casual contacts. Health authorities may recommend prophylaxis for close household contacts of severe pediatric cases or for cluster situations. The decision is made by public health departments on a case-by-case basis.
How does iGAS relate to scarlet fever?
Scarlet fever is a superficial Group A Strep infection with the characteristic sandpaper rash, caused by toxin-producing strains. Most scarlet fever resolves with antibiotics and does not progress to iGAS. The surge in pediatric iGAS in 2022-2023 coincided with a scarlet fever wave in some European countries because the underlying strain mix was the same.
Why is M1UK more virulent?
The M1UK strain produces approximately 9 times more streptococcal pyrogenic exotoxin A (SpeA) than parent M1 strains. SpeA is a superantigen that triggers massive T-cell activation and cytokine release. The toxin-mediated component is what drives severe scarlet fever and toxic shock syndrome.